Drawing for CHAI

USPTO serial 99841144

CHAI

Reviewed by CopyMark Law Group

Status 661
Filing date
Status date
Registration date
—
Examiner
SINGER, MELANIE ALYSSA
Law office
TMO LAW OFFICE 112

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CHAI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

J. Charles Dougherty

J. Charles Dougherty Wright, Lindsey & Jennings LLP200 W. Capitol Ave., Ste. 2300Little Rock, AR 72201United States

Goods and services

ClassDescriptionStatusFirst use
035Business management consulting services in the field of health systems administration; supply chain management consulting services for health commodities; market research services in the fields of pharmaceuticals, diagnostics, vaccines, and medical devices; market analysis services, namely, compiling and analyzing market data relating to pricing, supply, and access to health commodities; procurement services, namely, negotiating prices and contractual terms for health commodities on behalf of third parties; demand aggregation services for health commodity procurement; business administration services for donor-funded global health programs; business research in the field of health economics and economic modeling being forecasting and analysis of costs and costs effectiveness of health interventions; public policy advisory services to governments for the development of regulatory frameworks for artificial intelligence in healthcare; business strategic planning of health policy and advisory services related to public policy development; operational business assistance to enterprises for the implementation and management of national health programs; providing regulatory affairs consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval for pharmaceutical, diagnostic, and medical device products, namely, advising on regulatory approval pathways; public policy advisory services to governments relating to the development of national assistive technology policies and supply chain frameworksACTIVE—
036Financial advisory services in the fields of program administration for health financing, health budget analysis, and health insurance design; administration of donor-funded grant programs in the field of global health; lending and financing services, namely, providing credit facilities to facilitate access to pharmaceutical and medical innovations.ACTIVE—
041Education and training services, namely, conducting training programs, workshops, seminars, and field-based mentorship for healthcare workers, government health officials, and health system managers in the field of healthcare policy; developing and providing training-of-trainers programs in the field of healthcare; developing and disseminating printed educational materials in the fields of public health and health systems management; publishing research reports, policy briefs, market analyses, and technical fact sheets in the fields of global health and health policy.ACTIVE—
042Scientific research services in the fields of public health, epidemiology, and health economics; health economics research, namely, modeling the costs and cost-effectiveness of health interventions; geospatial mapping analysis and mapping services in the field of public health; design and development of software platforms for health data management, health facility performance monitoring, and disease campaign management; design and development of data visualization tools and dashboards for health resource planning; technology consulting services in the field of artificial intelligence applications for health systems, namely, computer-aided diagnostics and clinical decision support; AI product development consulting services to developers of artificial intelligence software relating to providing healthcare and global health domain expertise to inform the design and development of artificial intelligence systems; quality assurance consulting services for pharmaceutical and diagnostic product manufacturers; technology advisory services related to healthcare policy; technical advisory and facilitation services in the nature of research and development for pharmaceutical technology transfer and generic medicine developmentACTIVE—
044Public health consulting and advisory services for governments, ministries of health, and public health stakeholders in the nature of medical public health guidance for international travelers; assistive technology needs medical assessment and screening services for individuals with disabilities for medical treatment servicesACTIVE—
045Regulatory compliance advisory services to governments for the development of regulatory frameworks for artificial intelligence in healthcareACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 30, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 30, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 30, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 25, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 25, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 25, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2026DOCKASSIGNED TO EXAMINER—
Sep 21, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 22, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
May 22, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance